BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17825396)

  • 1. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstaging of cervical cancer.
    Ananth R
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker.
    Bhatla N; Mukhopadhyay A; Joshi S; Kumar A; Kriplani A; Pandey RM; Verma K
    Indian J Cancer; 2004; 41(1):32-6. PubMed ID: 15105577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer control in developing countries: memorandum from a WHO meeting.
    Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low cost methods for secondary prevention of cervical cancer in developing countries.
    Anorlu RI; Ola ER; Abudu OO
    Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization for cervical cancer screening: lessons from a poor-urban Yoruba community in Nigeria.
    Thomas JO; Babarinsa IA; Ajayi IO; Fawole O; Ojemakinde KO; Omigbodun AO
    Afr J Med Med Sci; 2005 Mar; 34(1):81-5. PubMed ID: 15973782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou screening in developing countries: an idea whose time has come.
    Suba EJ; Raab SS;
    Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New adjunctive methods for cervical cancer screening.
    Schneider A; Zahm DM
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):657-73. PubMed ID: 8869951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
    Gaikwad NL; Mahajan NN; Mahajan KN
    Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):258-9; author reply 259. PubMed ID: 17550500
    [No Abstract]   [Full Text] [Related]  

  • 12. Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria.
    Miller D; Okolo CA; Mirabal Y; Guillaud M; Arulogun OS; Oladepo O; Crain B; Follen M; Adewole IF
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S196-207. PubMed ID: 17889285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: screening and therapeutic perspectives.
    Sankaranarayanan R; Thara S; Esmy PO; Basu P
    Med Princ Pract; 2008; 17(5):351-64. PubMed ID: 18685274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cervical cancer screening for prevention of carcinoma cervix.
    Christe DM; Mohanambal M; Ramamurthy V; Snehaa NB
    J Indian Med Assoc; 2008 Dec; 106(12):779-80, 782. PubMed ID: 19370947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to cervical cancer screening in Latin America and the Caribbean.
    Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
    Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mobile-phone based high-resolution microendoscope to image cervical precancer.
    Grant BD; Quang T; Possati-Resende JC; Scapulatempo-Neto C; de Macedo Matsushita G; Mauad EC; Stoler MH; Castle PE; Guerreiro Fregnani JHT; Schmeler KM; Richards-Kortum R
    PLoS One; 2019; 14(2):e0211045. PubMed ID: 30726252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.